Abstract
Computer-based analysis revealed that natural products exhibit a remarkable structural diversity of molecular frameworks and scaffolds that could be systematically exploited for combinatorial synthesis. Natural products offer a rich pool of unique molecular frameworks that complement “drug space”. They possess desirable druglike properties rendering them ideal starting points for molecular design considerations. This review provides an overview of chemotype diversity and molecular properties of collections of drugs and druglike molecules, pure natural products, and natural productderived compounds. Compared to druglike molecules, pure natural products contain more oxygen atoms and chiral centers, and have less aromatic atoms on average. Among the natural product library we identified more than one thousand scaffolds that were not contained in any other compound set analyzed. This outcome provides a basis for the design of new natural product-derived compound libraries. Our study demonstrates that computational chemical biology can assist in finding suitable molecular entities in collections of natural products for drug discovery.
Keywords: Natural products, drug discovery, combinatorial chemistry, library design, virtual screening
Current Chemical Biology
Title: Properties and Architecture of Drugs and Natural Products Revisited
Volume: 1 Issue: 1
Author(s): Kristina Grabowski and Gisbert Schneider
Affiliation:
Keywords: Natural products, drug discovery, combinatorial chemistry, library design, virtual screening
Abstract: Computer-based analysis revealed that natural products exhibit a remarkable structural diversity of molecular frameworks and scaffolds that could be systematically exploited for combinatorial synthesis. Natural products offer a rich pool of unique molecular frameworks that complement “drug space”. They possess desirable druglike properties rendering them ideal starting points for molecular design considerations. This review provides an overview of chemotype diversity and molecular properties of collections of drugs and druglike molecules, pure natural products, and natural productderived compounds. Compared to druglike molecules, pure natural products contain more oxygen atoms and chiral centers, and have less aromatic atoms on average. Among the natural product library we identified more than one thousand scaffolds that were not contained in any other compound set analyzed. This outcome provides a basis for the design of new natural product-derived compound libraries. Our study demonstrates that computational chemical biology can assist in finding suitable molecular entities in collections of natural products for drug discovery.
Export Options
About this article
Cite this article as:
Grabowski Kristina and Schneider Gisbert, Properties and Architecture of Drugs and Natural Products Revisited, Current Chemical Biology 2007; 1 (1) . https://dx.doi.org/10.2174/2212796810701010115
DOI https://dx.doi.org/10.2174/2212796810701010115 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Carnosine and Lung Disease
Current Medicinal Chemistry Antimitotic Chalcones and Related Compounds as Inhibitors of Tubulin Assembly
Anti-Cancer Agents in Medicinal Chemistry Nebulizer Therapy in Pulmonology: Review of the Literature
Current Respiratory Medicine Reviews Good Uptake of the COVID-19 Vaccine among Patients with Rheumatic Diseases in the United Arab Emirates (UAE)
New Emirates Medical Journal Role of Sulfonamide Group in Matrix Metalloproteinase Inhibitors
Current Medicinal Chemistry ABC Transporters in the CNS – An Inventory
Current Pharmaceutical Biotechnology Peptoids: Bio-Inspired Polymers as Potential Pharmaceuticals
Current Pharmaceutical Design Editorial [Hot Topic: In Silico Lead Identification and Optimization for Drug Discovery (Executive Guest Editor: Shuxing Zhang)]
Current Pharmaceutical Design Post COVID-19 Lockdown in Ghana: What is the Wellbeing Status of the Young Adults?
Current Hypertension Reviews Biological Activities of Quinoline Derivatives
Mini-Reviews in Medicinal Chemistry Opioid Ligands Having Delayed Long-Term Antagonist Activity: Potential Pharmacotherapies for Opioid Abuse
Mini-Reviews in Medicinal Chemistry Converting Peptides into Drug Leads by Lipidation
Current Medicinal Chemistry Recent Developments of Quinoline Derivatives and their Potential Biological Activities
Current Organic Synthesis Feruloyl Sucrose Esters: Potent and Selective Inhibitors of α-glucosidase and α-amylase
Current Medicinal Chemistry Macromolecular Bases of Antischistosomal Therapy
Current Topics in Medicinal Chemistry Quetiapine to Treat Agitation in Dementia: A Randomized, Double-Blind,Placebo-Controlled Study
Current Alzheimer Research Editorial [Is Drug Safety Dangerous?]
Current Drug Safety SARS-CoV-2: Possible Factors Contributing to Serious Consequences of COVID-19?
New Emirates Medical Journal Potential Neuroprotective Effect of Cannabinoids in COVID-19 Patients
Current Topics in Medicinal Chemistry Message from the President of Emirates Medical Association
New Emirates Medical Journal